Clinical trial
An Observational Study of Patients With Chronic Hepatitis B (CHB) Infection
NCT03692897 is registered in ClinicalTrials.gov with Target PharmaSolutions, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Observational Study of Patients With Chronic Hepatitis B (CHB) Infection
- Lead sponsor
- Target PharmaSolutions, Inc.
- Phase
- Observational
- Overall status
- Terminated
- Start date
- October 11, 2018
- Completion date
- September 10, 2025
- Enrollment
- 1,708 (actual)
- Sites
- 31
Conditions
As the registry lists them; a condition with its own page is linked.